In PTEN mutation negative CS/CSL, KLLN germline promoter hypermethylation is observed in up to 35% of patients and is associated with three-fold increased prevalence of breast carcinomas and two-fold increased prevalence of renal cell carcinomas [2, 5, 6]. Here, KLLN is linked to hereditary clear cell renal cell carcinoma.